Scientists have learned more about how to protect the insulin-producing cells that die in patients with Type 1 diabetes.

PNNL researchers helped identify a fragment from the SARS-CoV-2 virus that spurs severe illness.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

Scientists have opened a new view into the workings of the central nervous system, finding a diverse set of important molecules.

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

The Washington State Academy of Sciences consists of more than 300 elected members who are nationally recognized for their scientific and technical expertise.

Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.

A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.

A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.

Scientists are exploring the use of deep neural network to interpret highly technical data related to national security, the environment and the cosmos.

Fifteen PNNL scientists are part of a team that has identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Scientist-detectives put themselves to the test.

The Multi-omics for Microbiomes conference focused on different approaches that let researchers paint better pictures of microbial communities.

Pointing the finger at chemical criminals: Several scientists from PNNL and other institutions will discuss new methods and approaches at the American Chemical Society's national meeting in San Francisco April 2-6.

Two teams honored for transferring PNNL developed technologies to market.

Nuisance alarm rates in radiation detectors at seaports and ports of entry are down significantly due to PNNL data analysis efforts that are saving time and money at the ports.